The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intravesical recombinant BCG combined with chemo-immunotherapy (chemo-IO) as perioperative therapy for patients with muscle-invasive bladder cancer (MIBC): Primary analysis of SAKK 06/19.
 
Richard Cathomas
Honoraria - Astellas Pharma (Inst); AstraZeneca (Inst); Johnson & Johnson/Janssen; Merck KGaA (Inst)
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Johnson & Johnson/Janssen; MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst)
 
Ulf Petrausch
Consulting or Advisory Role - AstraZeneca (Inst); BMS GmbH & Co. KG (Inst); MSD (Inst); Roche Africa (Inst)
Research Funding - AstraZeneca (Inst); BMS GmbH & Co. KG (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Stefanie Hayoz
No Relationships to Disclose
 
Lukas Bubendorf
No Relationships to Disclose
 
Martin Spahn
No Relationships to Disclose
 
Philipp Niederberger
No Relationships to Disclose
 
Frank Stenner
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; BMS GmbH & Co. KG; MSD; Roche
Research Funding - Takeda (Inst)
Expert Testimony - Roche
Travel, Accommodations, Expenses - Roche
 
Anita Hirschi
Travel, Accommodations, Expenses - Stemline Therapeutics
 
Ursula Vogl
Consulting or Advisory Role - Astellas Pharma; AstraZeneca (Inst); Bayer; BMS GmbH & Co. KG (Inst); Johnson & Johnson/Janssen (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst)
 
Anja Lorch
Honoraria - Astellas Oncology; AstraZeneca; Bayer; BMS GmbH & Co. KG; Eisai; Ipsen; Janssen; Merck KGaA; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Bayer; BMS GmbH & Co. KG; Eisai; Ipsen; Janssen; Merck KGaA; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Janssen
 
Petros Tsantoulis
Consulting or Advisory Role - Astellas Oncology; Bayer; BMS GmbH & Co. KG; Ipsen; Johnson & Johnson; Merck KGaA; MSD; Novartis; Pfizer; Roche; Sanofi
Speakers' Bureau - Bayer; Johnson & Johnson; MSD
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Johnson & Johnson; Lilly; Sanofi
 
Stefanie Aeppli
No Relationships to Disclose
 
Andreas Erdmann
No Relationships to Disclose
 
Raeto Strebel
No Relationships to Disclose
 
Angela Fischer Maranta
No Relationships to Disclose
 
Christian Fankhauser
No Relationships to Disclose
 
Sabrina Chiquet
No Relationships to Disclose
 
Sacha Rothschild
Honoraria - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Otsuka (Inst); Pfizer (Inst); PharmaMar (Inst); Roche Diagnostics Solutions (Inst); Roche Pharma AG (Inst); Sanofi (Inst); Takeda (Inst)
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Otsuka (Inst); Pfizer (Inst); PharmaMar (Inst); Roche Pharma AG (Inst); Takeda (Inst); Thermo Fisher Scientific (Inst)
Speakers' Bureau - Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Johnson & Johnson/Janssen (Inst); Roche Pharma AG (Inst); Sanofi/Aventis (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Roche Pharma AG (Inst); Sanofi; Takeda (Inst)
Other Relationship - Federal Drug Commission of the Swiss Federal Office of Public Health; Swiss Cancer Institute (SCI) (Inst)
 
Cyrill Rentsch
No Relationships to Disclose